Ipca Laboratories Ltd.

IPCALAB Share PricePharmaceuticals & Drugs

1,465.9

-6 (-0.4%)

As on December 12, 2025

Exchange Scrips: BSE524494NSEIPCALABISININE571A01038

Market Cap37,191 Cr

P/E Ratio 50.41

Dividend Yield 0.27 %

Performance

Market performance

Open1,478.3
High1,487.9
Volumes98,690
Prev1,465.9
Low1,458.9
As on2025-12-12

Historical performance

1 Year High1,755.9
3 Year High1,755.9
5 Year High1,755.9
1 Year Low1,168.2
3 Year Low669.8
5 Year Low669.8

Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
37,191
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
50.41
Dividend Yield
Dividend Yield
0.27 %

Investment Returns

1 Year
-6.1%
3 Years
70.1%
5 Years
32.6%
10 Years
291.6%

Technicals

IndicatorsValueSignal
5-DMA1,460.5Bullish
10-DMA1,450.99Bullish
20-DMA1,440.98Bullish
50-DMA1,364.39Bullish
100-DMA1,376.93Bullish
200-DMA1,388.34Bullish

Shareholding Pattern

FieldSep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Promoters1416161616
Foreign Investors---------------
Domestic Investors1416161616
Public Investors8285685566882909017382959
Government---------------

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 50.41.
  • 3Y Stock Price CAGR of the stock is 19.2.
  • The stock has a beta of 0.8.
  • In the last financial year, the company had an EBITDA of ₹18218 Million.
  • The company generated revenue of ₹88968 Million in the previous financial year.

Ipca Laboratories Ltd.

1465.9-6   (-0.4%)

Investment Amount: ₹ 1000000
Current Value: ₹ 936019.4
No. of Shares: 639 (Approx)
Performance:-6.4%
P/L: ₹-63980.6

Top Gainers

SymbolChange%
MAHAPEXLTD95.24(20%)
VIPULLTD10.24(20%)
TVVISION7.77(20%)
TARIL280.2(17%)
WALCHANNAG175.53(14%)

Top Losers

SymbolChange%
REFEX254.9(-20%)
VLSFINANCE299.45(-10%)
BALAXI30.06(-9%)
VLEGOV21.01(-9%)
KSR17.33(-9%)
ASMS12.2(-8%)
VINNY1.28(-7%)
RAJSREESUG37.79(-6%)

Peer Comparison

Venus Remedies Ltd.

53.5%

825.4

1 Month Performance

Nectar Lifesciences Ltd.

48.7%

21.04

1 Month Performance

SMS Pharmaceuticals Ltd.

11.4%

320.7

1 Month Performance

Natco Pharma Ltd.

10.1%

905.65

1 Month Performance

Haleos Labs Ltd.

9.8%

1386.8

1 Month Performance

Zota Health Care Ltd.

9%

1670.2

1 Month Performance

Emcure Pharmaceuticals Ltd.

7.6%

1438.6

1 Month Performance

Glenmark Pharmaceuticals Ltd.

6.9%

1975

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month